Early response and safety of lenvatinib for patients with advanced hepatocellular carcinoma in a real-world setting

被引：0
|
作者：
Sho, Takuya [1 ]
Suda, Goki [1 ]
Ogawa, Koji [1 ]
Nakai, Masato [1 ]
Morikawa, Kenichi [1 ]
Sakamoto, Naoya [1 ]
机构：
[1] Hokkaido Univ, Sapporo, Hokkaido, Japan
来源：
JOURNAL OF HEPATOLOGY | 2019年 / 70卷 / 01期
关键词：
D O I：
10.1016/S0618-8278(19)31240-X
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
FRI-505
引用
收藏
页码：E621 / E621
页数：1
相关论文
共 50 条
  • [31] Real-world safety and tolerability data for lenvatinib use in unresectable hepatocellular cancer
    Celermajer, Y.
    Prince, D.
    Stratton, E.
    Davidson, S.
    Majumdar, A.
    Mccaughan, G.
    Levy, M.
    Strasser, S.
    Liu, K.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 : 42 - 43
  • [32] REAL-WORLD SAFETY AND TOLERABILITY DATA FOR LENVATINIB USE IN UNRESECTABLE HEPATOCELLULAR CANCER
    Celermajer, Yael
    Prince, David S.
    Stratton, Elisabeth
    Davidson, Scott
    Majumdar, Avik
    McCaughan, Geoffrey W.
    Levy, Miriam T.
    Strasser, Simone I.
    Liu, Ken
    HEPATOLOGY, 2020, 72 : 704A - 704A
  • [33] Real-World Efficacy and Safety of Lenvatinib in Advanced or Recurrent Thymic Carcinoma: A Multicenter Retrospective Study in Japan
    Miyamoto, Satoshi
    Tsukaguchi, Akihiro
    Kuhara, Hanako
    Otsuki, Taiichiro
    Shiroyama, Takayuki
    Tamiya, Motohiro
    Tamiya, Akihiro
    Nishino, Kazumi
    Takeda, Yoshito
    Kijima, Takashi
    Okumura, Meinoshin
    Kumanogoh, Atsushi
    Mori, Masahide
    THORACIC CANCER, 2025, 16 (06)
  • [34] Real-World Data for Lenvatinib in Hepatocellular Carcinoma (ELEVATOR): A Retrospective Multicenter Study
    Welland, Sabrina
    Leyh, Catherine
    Finkelmeier, Fabian
    Jefremow, Andre
    Shmanko, Kateryna
    Gonzalez-Carmona, Maria A.
    Kandulski, Arne
    Jeliazkova, Petia
    Best, Jan
    Fruendt, Thorben W.
    Djanani, Angela
    Pangerl, Maria
    Maieron, Andreas
    Greil, Richard
    Fricke, Christina
    Sookthai, Disorn
    Guenther, Rainer
    Schmiderer, Andreas
    Wege, Henning
    Venerito, Marino
    Ehmer, Ursula
    Mueller, Martina
    Strassburg, Christian P.
    Weinmann, Arndt
    Siebler, Jurgen
    Waidmann, Oliver
    Lange, Christian M.
    Saborowski, Anna
    Vogel, Arndt
    LIVER CANCER, 2022, 11 (03) : 219 - 232
  • [35] Lenvatinib for the treatment of hepatocellular carcinoma—a real-world multicenter Australian cohort study
    Kurvi Patwala
    David Stephen Prince
    Yael Celermajer
    Waafiqa Alam
    Eldho Paul
    Simone Irene Strasser
    Geoffrey William McCaughan
    Paul Gow
    Siddharth Sood
    Elise Murphy
    Stuart Roberts
    Elliot Freeman
    Elizabeth Stratton
    Scott Anthony Davison
    Miriam Tania Levy
    McCawley Clark-Dickson
    Vi Nguyen
    Sally Bell
    Amanda Nicoll
    Ashley Bloom
    Alice Unah Lee
    Marno Ryan
    Jessica Howell
    Zina Valaydon
    Alexandra Mack
    Ken Liu
    Anouk Dev
    Hepatology International, 2022, 16 : 1170 - 1178
  • [36] Comparative efficacy of tislelizumab plus lenvatinib and tislelizumab alone against advanced hepatocellular carcinoma after lenvatinib failure: a real-world study
    Jiajin Yang
    Qiuping Xu
    Sihao Luo
    Jianbing Wu
    BMC Cancer, 25 (1)
  • [37] REAL WORLD EVIDENCE OF LENVATINIB IN ADVANCED HEPATOCELLULAR CARCINOMA: A MULTICENTER COHORT STUDY
    Nakano, Masahito
    Kuromatsu, Ryoko
    Niizeki, Takashi
    Okamura, Shusuke
    Iwamoto, Hideki
    Shimose, Shigeo
    Shirono, Tomotake
    Noda, Yu
    Kamachi, Naoki
    Koga, Hironori
    Torimura, Takuji
    HEPATOLOGY, 2019, 70 : 243A - 244A
  • [38] Lenvatinib combined with nivolumab in advanced hepatocellular carcinoma-real-world experience
    Wen-Chi Wu
    Tzu-Yuan Lin
    Ming‑Huang Chen
    Yi‑Ping Hung
    Chien-An Liu
    Rheun‑Chuan Lee
    Yi‑Hsiang Huang
    Yee Chao
    San-Chi Chen
    Investigational New Drugs, 2022, 40 : 789 - 797
  • [39] Lenvatinib combined with nivolumab in advanced hepatocellular carcinoma-real-world experience
    Wu, Wen-Chi
    Lin, Tzu-Yuan
    Chen, Ming-Huang
    Hung, Yi-Ping
    Liu, Chien-An
    Lee, Rheun-Chuan
    Huang, Yi-Hsiang
    Chao, Yee
    Chen, San-Chi
    INVESTIGATIONAL NEW DRUGS, 2022, 40 (04) : 789 - 797
  • [40] Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: A real-world study
    Chon, Young Eun
    Kim, Dong Yun
    Kim, Mi Na
    Kim, Beom Kyung
    Kim, Seung Up
    Park, Yong
    Ahn, Sang Hoon
    Ha, Yeonjung
    Lee, Joo Ho
    Lee, Kwan Sik
    Kang, Beodeul
    Kim, Jung Sun
    Chon, Hong Jae
    Kim, Do Young
    CLINICAL AND MOLECULAR HEPATOLOGY, 2024, 30 (03)
12345